Friday, April 18, 2025

Yearly Archives: 2020

Coronavirus (COVID-19) Update: December 28, 2020

December 28, 2020: "The U.S. FDA announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: On Dec. 23, the FDA...

Lynparza approved in Japan for the treatment of advanced ovarian, prostate and pancreatic cancers

December 28, 2020: "AstraZeneca and MSD’s Lynparza (olaparib) has been approved in Japan for the treatment of advanced ovarian, prostate and pancreatic cancers. The three approvals authorise Lynparza for:...

FDA Approves First Generic of Drug Used to Treat Severe Hypoglycemia

December 28, 2020: "The U.S. FDA approved the first generic of glucagon for injection USP, 1 mg/vial packaged in an emergency kit, for the...

FDA Takes Further Steps to Confront Opioid Crisis

December 23, 2020: "While our efforts to combat COVID-19 remain at the forefront of our day-to-day activities, the U.S. FDA also continues its work...

CDC to Require Negative COVID-19 Test for Air Travelers from U.K. to U.S.

December 24, 2020: "President Trump is taking another step to protect the health of the American people by requiring air passengers arriving from the...

FDA authorizes marketing of new device designed to remove dead pancreatic tissue

December 23, 2020: The U.S. FDA authorized marketing of the EndoRotor System to resect (cut out) and remove necrotic (dead) tissue for patients with...

Ocugen and Bharat biotech to co-develop Covaxin™ for the us market

December 22, 2020: "Ocugen, Inc., a leading biopharmaceutical company, and Bharat Biotech, a global leader in vaccine innovation announced that the companies have signed...

Pfizer and BioNTech to Supply the U.S. with 100 Million Doses of COVID-19 Vaccine

December 23, 2020: "Pfizer Inc. and BioNTech SE announced a second agreement with the U.S. government to supply an additional 100 million doses of the companies’...

Ridgeback Biotherapeutics LP Announces the Approval of EbangaTM for Ebola

December 22, 2020: Ridgeback Biotherapeutics LP, a biotechnology company experienced in antiviral drug development, announced today that the U.S.FDA approved EbangaTM for the treatment of...

FDA Warns Companies Illegally Selling CBD Products

December 22, 2020: "The U.S. FDA issued five warning letters to companies for selling products containing cannabidiol (CBD) in ways that violate the Federal...

EU nod for first long-acting HIV injectable treatment

Marketing Authorisation granted by European Commission for ViiV Healthcare’s Vocabria (cabotegravir injection and tablets) to be used with Janssen’s Rekambys (rilpivirine injection) and Edurant...

Pfizer and BioNTech Receive Authorization in the EU for COVID-19 Vaccine

 December 21, 2020: "Pfizer and BioNTech announced that the European Commission (EC) has granted a conditional marketing authorization (CMA) to Pfizer and BioNTech for COMIRNATY® (also...
- Advertisment -

Most Read